Endotoxins: Clinical Trials

52 trials of Endotoxins, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

45 completed, 2 not yet recruiting, 2 recruiting, 1 enrolling by invitation. 20 Phase 1, 15 Not applicable, 7 Early Phase 1, 7 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 120Completed 18, Not yet recruiting 1, Terminated 1
Not applicable15Completed 14, Recruiting 1
Early Phase 17Completed 7
Phase 27Completed 4, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1
Phase 32Completed 2
Phase 42Completed 1, Unknown 1

Follow Endotoxins: new trials by email Literature Review of Endotoxins trials Research Report on Endotoxins

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Endotoxin Exposure to Examine the Role of Inflammation in Alcohol Use
Endotoxin, Placebo saline - Alcohol Use Disorder, Inflammatory Response
Phase 2Not yet recruitingUniversity of California, Los Angeles642026-09-012026-08-28
Inflammatory Challenge in Human Aggression.
Endotoxin (E. coli O:113, Reference Endotoxin), Saline (Placebo) - Intermittent Explosive Disorder
Phase 2RecruitingOhio State University1122026-02-162026-03-27
Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function
Short-Chain Fatty Acid Colon-Delivery Capsules, Placebo capsules, Lipopolysaccharide (LPS) - Endotoxemia, Inflammation
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven562025-10-242026-07-20
Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
Dexamethasone, Tocilizumab, Anakinra - Sepsis, Neuroinflammatory Response
Phase 4UnknownRadboud University Medical Center522024-10-242025-04-04
Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma
Lipopolysaccharides - Asthma; Eosinophilic, Asthma
Phase 1Not yet recruitingNational Jewish Health602024-04-012024-02-21
Aging and Reward System Response to Inflammation and Anxiety Study
Endotoxin, Placebo - Anhedonia, Inflammation
Phase 1CompletedUniversity of California, Los Angeles402023-03-292025-12-11
Effect of Endotoxin on Alcohol Consumption
Endotoxin - Alcohol Use Disorder
Phase 2CompletedYale University272022-02-272025-11-03
An Inflammatory Challenge Using Endotoxin
Placebo, Endotoxin - Alcohol Use Disorder, Inflammatory Response
Phase 2CompletedUniversity of California, Los Angeles202021-10-192025-05-01
The Innate Central Nervous System Immune Response to an Experimental Immune Challenge in People With Fibromyalgia
Endotoxin, Escherichia Coli, Magnetic Resonance Spectroscopy - Fibromyalgia
Phase 2 / Phase 3CompletedUniversity of Alabama at Birmingham362020-03-112023-04-14
Sleep and Healthy Aging Research on Depression for Younger Women
Endotoxin, Placebo - Anhedonia, Depression
Phase 1CompletedUniversity of California, Los Angeles402019-10-022026-01-27
Determining the Fingerprint of Endotoxin Tolerance
Endotoxin (E. coli O:113, Reference Endotoxin) - Endotoxemia, Sepsis
Not applicableCompletedRadboud University Medical Center1102019-05-272025-02-07
A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants
Imvanex, Shingrix, LPS - Healthy
Early Phase 1CompletedJanssen Research & Development, LLC482019-04-082025-02-03
Effects of 20,000 EU of Clinical Center Reference Endotoxin (CCRE) Versus Placebo(ENDOHEART)
Clinical Center Reference Endotoxin (CCRE), Normal saline - Healthy
Phase 1CompletedUniversity of North Carolina, Chapel Hill152018-10-172019-09-20
The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells
LPS, Placebo - Sepsis, Endotoxemia, Immunosuppression
Not applicableCompletedRadboud University Medical Center122018-01-052022-10-06
Systemic Inflammatory Response to CCRE
CCRE - Healthy
Phase 1CompletedUniversity of North Carolina, Chapel Hill252017-12-112019-09-20
Lipopolysaccharide (LPS) Challenge in Depression
Lipopolysaccharide, Placebo - Major Depressive Disorder
Phase 1CompletedLaureate Institute for Brain Research, Inc.642017-09-072025-07-02
Sleep and Healthy Aging Research for Depression (SHARE-D) Study
Endotoxin, Placebo - Depression in Old Age
Phase 1CompletedMichael Irwin, MD1602017-08-232024-09-05
Adrecizumab-LPS Study
Endotoxin, Placebo, Adrecizumab - Healthy Volunteers
Phase 1CompletedAdrenomed AG242017-01-042021-02-01
Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans
Endotoxin, Placebo - Healthy
Phase 1CompletedRobert J Noveck, M.D.232016-08-012017-04-11
Effects of Bronchial Segmental Endotoxin Instillation in Humans
Saline, Endotoxin - Acute Lung Inflammation
Phase 2Enrolling by invitationNational Institutes of Health Clinical Center (CC)582015-06-182026-10-16

Showing 20 of 52. Sign in to see all of them.

Conditions studied

Endotoxemia (11)  ·  Inflammation (9)  ·  Sepsis (7)  ·  Depression (6)  ·  Pneumonia (4)  ·  Alcoholism (3)  ·  Illness Behavior (3)  ·  Anhedonia (2)  ·  Asthma (2)  ·  Insulin Resistance (2)  ·  Neuroinflammatory Diseases (2)  ·  Systemic Inflammatory Response Syndrome (2)  ·  Aggression (1)  ·  Anemia (1)  ·  Anxiety Disorders (1)

Sponsors

Radboud University Medical Center (10)  ·  University of California, Los Angeles (7)  ·  Karolinska Institutet (3)  ·  Rutgers, The State University of New Jersey (3)  ·  University of North Carolina, Chapel Hill (3)  ·  Washington University School of Medicine (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  National Institutes of Health Clinical Center (CC) (2)  ·  University of Pennsylvania (2)  ·  Aarhus University Hospital (1)  ·  Adrenomed AG (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Janssen Research & Development, LLC (1)  ·  Laureate Institute for Brain Research, Inc. (1)  ·  Michael Irwin, MD (1)

Countries

United States (28)  ·  Netherlands (11)  ·  Denmark (3)  ·  Belgium (2)  ·  United Kingdom (2)

Top investigators

Peter Pickkers, MD, PhD (4)  ·  Siobhan Corbett, MD (3)  ·  Anthony F Suffredini, M.D. (2)  ·  Lara Ray, PhD (2)  ·  Michael R Irwin, MD (2)  ·  Michelle Hernandez, MD (2)  ·  Boushra Dalile, PhD (1)  ·  Chloe C Boyle, PHD (1)  ·  Chloe C Boyle, PhD (1)  ·  David Peden, MD (1)  ·  Delphine Chen, MD (1)  ·  Delphine L Chen, MD (1)  ·  Delphine L. Chen, MD (1)  ·  Emil F. Coccaro, MD (1)

Results publications

PMID 41298372, PMID 16864730, PMID 19376240, PMID 19387330, PMID 19574441, PMID 20719303, PMID 22106246, PMID 23060625, PMID 23497455, PMID 23835341, PMID 24504737, PMID 24875672, PMID 25525182, PMID 25579865, PMID 25770082, PMID 26360770, PMID 26515417, PMID 27307305, PMID 28515092, PMID 29298938, PMID 30217536, PMID 30239561, PMID 30418539, PMID 30571184, PMID 30919998, PMID 31103547, PMID 31632316, PMID 35868533, PMID 35871638, PMID 37256193, PMID 40668551, PMID 41192236

NIH funding

2023 (1), K01AG072049 (1), K24AA025704 (1), R01HL073278 (1), R01MH091352 (1), R01MH133925 (1), R03AA028361 (1)